BioCentury | Apr 19, 2010
Finance

Public at last

diaDexus Inc. was founded in 1997 as a 50-50 joint venture between SmithKline Beecham and Incyte Pharmaceuticals Inc. (now Incyte Corp. (NASDAQ:INCY)) to commercialize molecular diagnostics. It's one of the first companies formed with the...
BC Week In Review | Mar 2, 2009
Company News

A.P. Pharma management update

A.P. Pharma Inc. (NASDAQ:APPA), Redwood City, Calif.   Business: Drug delivery   Hired: John Whelan as VP of finance and CFO, formerly COO and CFO of Raven Biotechnologies Inc. (now part of MacroGenics Biotechnologies Inc.);...
BioCentury | Sep 29, 2008
Finance

Ebb & Flow

Sequenom (NASDAQ:SQNM) has more than quadrupled its market cap to $1.6 billion from $350 million since early June, when the company released initial data on its Down syndrome test. The $1.2 billion uptick equates to...
BC Week In Review | Jul 21, 2008
Company News

MacroGenics, Raven deal

MacroGenics acquired Raven for an undisclosed amount of stock. Raven has a platform technology to generate mAbs against cancer stem cells (CSCs), which the companies said complements MacroGenics’ Fc-optimization and next-generation antibody engineering platforms. Raven’s...
BioCentury | Jul 21, 2008
Strategy

Raven's better roost

MacroGenics Inc. hopes that its acquisition of Raven Biotechnologies Inc. will create a soup-to-nuts cancer antibody play. The deal, for an undisclosed amount of stock, combines MacroGenics' mAb engineering technologies with Raven's mAb generation platform....
BC Extra | Jul 18, 2008
Company News

MacroGenics acquiring Raven

MacroGenics (Rockville, Md.) acquired cancer company Raven (South San Francisco, Calif.) for an undisclosed amount of stock. Raven has a platform technology to generate mAbs against cancer stem cells (CSCs), which the companies said would...
BioCentury | Jul 7, 2008
Finance

Restructuring watch

Restructuring watch Date Company Staff cuts Cash Years cash pre-cut Cash date 1Q08 oper loss 4/2/08 Genitope (NASDAQ:GTOP) 89% to ~20 $12.4 0.06 3/31/08 $52.1 Seeking strategic alternatives, including the possible sale of its MyVax...
BC Week In Review | Apr 14, 2008
Company News

Monogram, Raven deal

Monogram will use its VeraTag assays to evaluate an undisclosed number of mAbs from Raven to diagnose cancer. The assays enable analysis of activated protein drug targets and signaling pathways in cancer cells. Monogram has...
BC Week In Review | Apr 14, 2008
Company News

Raven, Bioprocessing Technology Institute deal

Raven and the institute partnered to discover mAbs against cancer stem cells. The institute will use its stem cells and Raven's whole cell immunization technology to generate antibodies, which Raven will screen against its cancer...
BC Week In Review | Apr 14, 2008
Company News

VaxGen infectious news

VaxGen will restructure for a fourth time and reduce headcount by about 17 (75%) to 5 to minimize expenses following the termination of a proposed merger with Raven Biotechnologies Inc. (South San Francisco, Calif.). The...
Items per page:
1 - 10 of 67
BioCentury | Apr 19, 2010
Finance

Public at last

diaDexus Inc. was founded in 1997 as a 50-50 joint venture between SmithKline Beecham and Incyte Pharmaceuticals Inc. (now Incyte Corp. (NASDAQ:INCY)) to commercialize molecular diagnostics. It's one of the first companies formed with the...
BC Week In Review | Mar 2, 2009
Company News

A.P. Pharma management update

A.P. Pharma Inc. (NASDAQ:APPA), Redwood City, Calif.   Business: Drug delivery   Hired: John Whelan as VP of finance and CFO, formerly COO and CFO of Raven Biotechnologies Inc. (now part of MacroGenics Biotechnologies Inc.);...
BioCentury | Sep 29, 2008
Finance

Ebb & Flow

Sequenom (NASDAQ:SQNM) has more than quadrupled its market cap to $1.6 billion from $350 million since early June, when the company released initial data on its Down syndrome test. The $1.2 billion uptick equates to...
BC Week In Review | Jul 21, 2008
Company News

MacroGenics, Raven deal

MacroGenics acquired Raven for an undisclosed amount of stock. Raven has a platform technology to generate mAbs against cancer stem cells (CSCs), which the companies said complements MacroGenics’ Fc-optimization and next-generation antibody engineering platforms. Raven’s...
BioCentury | Jul 21, 2008
Strategy

Raven's better roost

MacroGenics Inc. hopes that its acquisition of Raven Biotechnologies Inc. will create a soup-to-nuts cancer antibody play. The deal, for an undisclosed amount of stock, combines MacroGenics' mAb engineering technologies with Raven's mAb generation platform....
BC Extra | Jul 18, 2008
Company News

MacroGenics acquiring Raven

MacroGenics (Rockville, Md.) acquired cancer company Raven (South San Francisco, Calif.) for an undisclosed amount of stock. Raven has a platform technology to generate mAbs against cancer stem cells (CSCs), which the companies said would...
BioCentury | Jul 7, 2008
Finance

Restructuring watch

Restructuring watch Date Company Staff cuts Cash Years cash pre-cut Cash date 1Q08 oper loss 4/2/08 Genitope (NASDAQ:GTOP) 89% to ~20 $12.4 0.06 3/31/08 $52.1 Seeking strategic alternatives, including the possible sale of its MyVax...
BC Week In Review | Apr 14, 2008
Company News

Monogram, Raven deal

Monogram will use its VeraTag assays to evaluate an undisclosed number of mAbs from Raven to diagnose cancer. The assays enable analysis of activated protein drug targets and signaling pathways in cancer cells. Monogram has...
BC Week In Review | Apr 14, 2008
Company News

Raven, Bioprocessing Technology Institute deal

Raven and the institute partnered to discover mAbs against cancer stem cells. The institute will use its stem cells and Raven's whole cell immunization technology to generate antibodies, which Raven will screen against its cancer...
BC Week In Review | Apr 14, 2008
Company News

VaxGen infectious news

VaxGen will restructure for a fourth time and reduce headcount by about 17 (75%) to 5 to minimize expenses following the termination of a proposed merger with Raven Biotechnologies Inc. (South San Francisco, Calif.). The...
Items per page:
1 - 10 of 67